Should patients with ventricular tachycardia be started on apixaban (Eliquis)?

No – Patients with Ventricular Tachycardia Should NOT Be Started on Eliquis

Eliquis (apixaban) is not indicated for ventricular tachycardia (VT) and should not be prescribed for this condition. The confusion here appears to stem from the abbreviation "VT," which in the anticoagulation literature refers to venous thromboembolism (VTE), not ventricular tachycardia.

Critical Distinction: VTE vs VT

The evidence provided discusses VTE (venous thromboembolism) – which includes deep vein thrombosis (DVT) and pulmonary embolism (PE) – not ventricular tachycardia. These are completely different conditions requiring entirely different management approaches:

Ventricular Tachycardia Management

• Does NOT require anticoagulation unless there is a separate indication (such as atrial fibrillation or VTE)
• Treatment focuses on:
  • Beta-blockers as first-line therapy 1, 2
  • Amiodarone for symptomatic sustained VT 3, 2
  • ICD (implantable cardioverter-defibrillator) for patients with depressed cardiac function or recurrent episodes 3, 1, 2
  • Catheter ablation in selected cases 2

When Anticoagulation IS Appropriate in Cardiac Patients

Eliquis would only be appropriate for a patient with VT if they have a separate, concurrent indication for anticoagulation:

1. Atrial fibrillation – Eliquis is FDA-approved for stroke prevention in nonvalvular AF 4
2. Venous thromboembolism (VTE) – Eliquis is FDA-approved for treatment and prevention of DVT/PE 4
   • Initial dosing: 10 mg twice daily for 7 days, then 5 mg twice daily 5
   • Extended therapy: Can reduce to 2.5 mg twice daily after 6 months 6

Common Clinical Pitfall

The most important pitfall to avoid is confusing the abbreviation "VT":

• In cardiology arrhythmia contexts: VT = Ventricular Tachycardia (rhythm disorder)
• In anticoagulation/thrombosis contexts: VT = Venous Thrombosis (clotting disorder)

The guidelines and drug labels you reference all discuss VTE/venous thrombosis, not ventricular arrhythmias 5, 6, 4.

Bottom Line

Do not prescribe Eliquis for ventricular tachycardia. If your patient has both ventricular tachycardia AND a separate indication for anticoagulation (such as concurrent atrial fibrillation or documented VTE), then Eliquis may be appropriate for the anticoagulation indication – but this decision should be based on the separate thrombotic risk, not the VT itself.